Corcept: Justin Gunn files initial Form 3 for 12,191 shares

Corcept's President, Corcept Endocrinology Justin Frederick Gunn filed a Form 3 showing 12,191 shares of common stock. Disclosure also lists stock options covering 72,397 shares, with exercise prices of $35.7, $37.94, $60.58.